ITSI-Biosciences Gets $100K SBIR Grant | GenomeWeb
NEW YORK (GenomeWeb News) – ITSI-Biosciences has received a $100,000 Small Business Innovation Research grant from the National Cancer Institute to support the firm’s ongoing breast cancer biomarker program.
The Johnstown, Pa.-based firm is developing a biomarker-based blood test to detect and classify breast malignancies. The SBIR grant will support the development of a multiplexed assay using a suspended array technology and the development of a prototype breast disease classification, the firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.